Covered recipient · General Payments record
PHILIPPE-ANTOINE BILODEAU
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2023–2024
$1,314.85
- Reported across 14 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,154.12 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| EMD Serono, Inc. | $408.48 | 3 |
| Alexion Pharmaceuticals, Inc. | $211.55 | 3 |
| Genentech USA, Inc. | $179.07 | 2 |
| GENZYME CORPORATION | $127.61 | 1 |
| Roche Products Limited | $126.25 | 1 |
| Biogen, Inc. | $101.16 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $35.66 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094036764 | CMS |
| Alexion Pharmaceuticals, Inc. | $118.75 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093961183 | CMS |
| Alexion Pharmaceuticals, Inc. | $57.14 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093963104 | CMS |
| Biogen, Inc. | $84.50 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104851748 | CMS |
| Biogen, Inc. | $16.66 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104825106 | CMS |
| EMD Serono, Inc. | $139.37 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120230206 | CMS |
| EMD Serono, Inc. | $125.09 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120230208 | CMS |
| EMD Serono, Inc. | $144.02 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120236490 | CMS |
| Genentech USA, Inc. | $33.02 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133089015 | CMS |
| Genentech USA, Inc. | $146.05 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133089011 | CMS |
| GENZYME CORPORATION | $127.61 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139901380 | CMS |
| Roche Products Limited | $126.25 | 04/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133089019 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.